DARE stock news · Dare Bioscience

Stories about Dare Bioscience (DARE) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for DARE

Follow Dare Bioscience (DARE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 12, 2026, 5:14 PM ET · Market
12 health care companies saw big changes in their stock prices after the market closed on Monday.
Neutral
Dare Bioscience shares rose about 5%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.
Oct 2, 2026, 4:06 PM ET · Trouble
Dare Bioscience, Inc. has been told it might be removed from Nasdaq for not meeting listing rules.
Bad for DARE
DARE received a Nasdaq notice after its closing bid stayed below $1.00 for 30 business days. Its listing is safe for now, but failure to recover could lead to delisting.
Sep 9, 2026, 10:23 AM ET · Market
Dare Bioscience, Inc. shares new info for upcoming meetings starting September 9, 2026.
Neutral
Dare filed an 8-K furnishing a corporate presentation dated Sept 9, 2026; this routine disclosure does not change the company's outlook.
Aug 17, 2026, 8:53 AM ET · Market
Dare Bioscience, Inc. secures a significant definitive agreement (DARE).
Bad for DARE
Dare Bioscience, Inc. has filed a Form 8-K indicating its entry into a material definitive agreement, which is likely to enhance its financial stability and growth opportunities. This news is crucial as it may lead to new funding or partnerships that can drive the company's future performance.